This infographic explores depression in patients with epilepsy, focusing on the impact of the COVID-19 pandemic. Questioning what healthcare professionals can do to help, this infographic analyses the epidemiology of depression and notes the differences between patients with controlled epilepsy and those with drug-resistant epilepsy.

David Heymann CBE shared his expertise with EMJ on public health and epidemiology, in the context of COVID-19 and previous disease outbreaks…

Ron Daniels offered insights to EMJ on the latest developments in sepsis care, and a look to the future for optimal diagnosis…

Thalassaemia is an autosomal recessive haematological disorder that is characterised by defective synthesis of the globin moiety in…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in general leads to a mild disease in children, but a rare yet serious…

Loeys–Dietz syndrome (LDS) is caused by connective tissue mutations; the resulting defective connective tissue in organs such as the eye…

The hypomethylating agents (HMA), azacitidine and decitabine, are currently regarded as the standard of care for patients with…

Myelodysplastic syndromes (MDS) are a rare group of blood disorders that can result in symptoms spanning from fatigue to easy bruising and bleeding. Based on a symposium that was part of the International Congress on Myelodysplastic Syndromes by the MDS Foundation, this article provides an overview of MDS.

David Oliver shared his thoughts with EMJ on his leadership and policy experience, his passion for advocacy in healthcare, and his work in…

Welcome to our first flagship EMJ journal of the year that has a mini-focus on COVID-19, sharing case studies alongside our article…